PA
API

PharVision Advisers’s Agora API Stock Holding History

PharVision Advisers’s Portfolio API Stock Details API Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.6K Sell
10,898
-64,783
-86% -$275K 0.39% 96
2025
Q4 		$308K Buy
75,681
+49,740
+192% +$183K 0.16% 254
2025
Q3 		$99.1K Buy
+25,941
New +$97.9K 0.06% 624

Other funds holding API

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TGP
TMT General Partner Hong Kong $250M AUM 6.05% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
YC
Yunqi Capital Hong Kong $92.4M AUM 16.3% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
NAH
Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return

PharVision Advisers's API Position: Q1 2026 in Review

PharVision Advisers reduced its Agora (API) stake by 86% in Q1 2026, selling an estimated $275K and leaving 10,898 shares worth $38.6K. The position accounts for 0.39% of the portfolio, ranked #96.

PharVision Advisers first reported a position in API in Q3 2025 and has held it in 3 quarters since. The position peaked at $308K in Q4 2025. 64 funds tracked by Wall St. Rank hold API as of Q1 2026.

  • PharVision Advisers held 10,898 shares of Agora worth $38.6K as of Q1 2026.
  • PharVision Advisers sold 64,783 Agora shares in Q1 2026, an estimated $275K.
  • Agora made up 0.39% of PharVision Advisers's portfolio in Q1 2026, its #96 holding.
  • PharVision Advisers first reported a position in Agora in Q3 2025 and has held it in 3 quarters since.
  • PharVision Advisers's Agora position peaked at $308K in Q4 2025.
  • 64 funds tracked by Wall St. Rank held Agora as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.